ALDH1A1 and acute myeloid leukemia: What is important in terms of disease outcome is that AML patients of the poor prognosis risk group show frequent elevation of RNA expression for the enzymes ALDH1A1 and ALDH2, and this elevation is associated with an increased risk of death [102].